Antimicrobial resistance

The University of Leeds is committed to addressing the growing global challenge of antimicrobial resistance (AMR).  Our AMR research involves researchers from across our faculties in a wide range of disciplines. We work to coordinate, foster and promote these research efforts, with the aim of achieving the greatest impact.

Antimicrobial agents, such as antibiotics, are our primary means of treating infectious diseases in humans and animals. Unfortunately, these drugs are rapidly becoming less effective, as microbes evolve to resist their effects, a phenomenon referred to as antimicrobial resistance or AMR.

If we don’t address AMR as a matter of urgency, over 300 million people worldwide are predicted to die prematurely by 2050.

Email: AMRresearch@leeds.ac.uk